Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Amelogenins are enamel matrix proteins with a proven ability to restore tissues in patients with advanced
periodontitis
and chronic skin wounds. To explore the mechanisms of action of amelogenins in wound inflammation, the in vitro effect on the expression of selected cell mediators involved in inflammation and tissue repair from human monocyte-derived macrophages was studied. Macrophages were treated with amelogenins in serum-enriched medium with simultaneous lipopolysaccharide (LPS) stimulation, for 6, 24 and 72 h, and the conditioned culture medium was analysed for 28 different cytokines. Amelogenin treatment directed the LPS-induced release of both pro- and anti-inflammatory cytokines towards an alternatively activated macrophage phenotype. This change in activation was also demonstrated by the amelogenin-induced secretion of alternative macrophage activation-associated CC chemokine-1 (
AMAC-1
, also known as
CCL18
; p<0.001), a well-documented marker of alternative activation. Amelogenins were also shown significantly to increase the macrophage expression of vascular endothelial growth factor and, to a lesser but significant extent, insulin-like growth factor-1 after 24h of culture. The results of the present in vitro study show that monocyte-derived macrophages stimulated by inflammatory agonist LPS respond to the treatment with amelogenins by reducing the pro-inflammatory activity and increasing the expression of tissue repair mediators.
...
PMID:Amelogenins modulate cytokine expression in LPS-challenged cultured human macrophages. 2237 12
Periodontitis
is a chronic inflammatory disease affecting the soft tissue and bone that surrounds the teeth. Despite extensive research, distinctive genes responsible for the disease have not been identified. The objective of this study was to elucidate transcriptome changes in
periodontitis
, by investigating gene expression profiles in gingival tissue obtained from
periodontitis
-affected and healthy gingiva from the same patient, using RNA-sequencing. Gingival biopsies were obtained from a disease-affected and a healthy site from each of 10 individuals diagnosed with
periodontitis
. Enrichment analysis performed among uniquely expressed genes for the
periodontitis
-affected and healthy tissues revealed several regulated pathways indicative of inflammation for the
periodontitis
-affected condition. Hierarchical clustering of the sequenced biopsies demonstrated clustering according to the degree of inflammation, as observed histologically in the biopsies, rather than clustering at the individual level. Among the top 50 upregulated genes in
periodontitis
-affected tissues, we investigated two genes which have not previously been demonstrated to be involved in
periodontitis
. These included interferon regulatory factor 4 and
chemokine (C-C motif) ligand 18
, which were also expressed at the protein level in gingival biopsies from patients with
periodontitis
. In conclusion, this study provides a first step towards a quantitative comprehensive insight into the transcriptome changes in
periodontitis
. We demonstrate for the first time site-specific local variation in gene expression profiles of
periodontitis
-affected and healthy tissues obtained from patients with
periodontitis
, using RNA-seq. Further, we have identified novel genes expressed in
periodontitis
tissues, which may constitute potential therapeutic targets for future treatment strategies of
periodontitis
.
...
PMID:Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing. 2302 19